Working… Menu

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial (ANEMEX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03214627
Recruitment Status : Terminated (Standard clinical practice at site caused unforeseen issues for the use of the ACM)
First Posted : July 11, 2017
Last Update Posted : January 7, 2020
Worldwide Clinical Trials
Fresenius Medical Care Deutschland GmbH
Information provided by (Responsible Party):
Vifor Fresenius Medical Care Renal Pharma